Acanthosis nigricans - 黒色表皮腫
☆ AI Dermatology — Free Service
ドイツの2022年Stiftung Warentestの結果では、ModelDermに対する消費者満足度は有料の遠隔医療相談よりもわずかに低いだけでした。
ドイツの2022年Stiftung Warentestの結果では、ModelDermに対する消費者満足度は有料の遠隔医療相談よりもわずかに低いだけでした。
この症状は肥満の人によく見られます。
relevance score : -100.0%
ReferencesAcanthosis nigricans は、基礎疾患に伴う皮膚症状です。多くの場合、首、脇の下、鼠径部などの皮膚のひだに現れ、境界が不明瞭なビロード様の黒い斑点として見られます。この状態は主に糖尿病やインスリン抵抗性と関連していますが、まれに体内のがんを示すこともあります。また、ホルモン異常やステロイド、経口避妊薬など特定の薬剤の服用によっても症状が出ることがあります。
Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives.
Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives.
Acanthosis nigricans (AN) は、インスリン抵抗性、糖尿病、肥満、特定の癌、ホルモンの問題、薬への反応など、さまざまな健康上の問題に関連する一般的な皮膚疾患です。AN の治療では、根本的な健康問題に対処することが重要です。まず、医師は肥満や高コレステロール、高血圧、2 型糖尿病など、インスリン抵抗性症候群の兆候がないかを検査します。多くの場合、皮膚の肥厚を抑える第一選択として topical retinoids を処方しますが、肌の黒ずみを完全に改善できるわけではありません。salicylic acid、podophyllin、urea、calcipotriol などの他の治療オプションも併用されることがあります。
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. Initial considerations for the AN workup include evaluating patients for insulin resistance syndrome characterized by obesity, dyslipidemia, hypertension, and diabetes mellitus type II. For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate. However, topical tretinoin requires application for long durations and improves hyperkeratosis, but not hyperpigmentation. Topical salicylic acid, podophyllin, urea, and calcipotriol also require frequent application, while TCA peels may provide a faster and less time-intense burden.
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. Initial considerations for the AN workup include evaluating patients for insulin resistance syndrome characterized by obesity, dyslipidemia, hypertension, and diabetes mellitus type II. For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate. However, topical tretinoin requires application for long durations and improves hyperkeratosis, but not hyperpigmentation. Topical salicylic acid, podophyllin, urea, and calcipotriol also require frequent application, while TCA peels may provide a faster and less time-intense burden.
○ 原因
40歳未満で発症することが多く、遺伝的要因が関与することがあります。また、肥満や甲状腺機能低下症、先端巨大症、多嚢胞性卵巣症候群、インスリン抵抗性糖尿病、クッシング症候群などの内分泌疾患と関連することがあります。
○ 治療 ― OTC医薬品
#40% urea cream